Logo Molina Healthcare

Molina Healthcare (MOH) stock: analyst price target and their real reliability

Live quote · data updated Aug 28, 2026
Molina Healthcare · Health Care · ref. ETF XLV · 106 calls · price $198.75
💬JPI AI AssistantTry it →
What the company does: Molina Healthcare, Inc. provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces in the United States.

📈 Molina Healthcare (MOH) stock price

$198.75+13.8% over range
Aug 28, 25low $122.65 · high $242.88Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
9% recommend buying · 11 analysts
📊 JPI status : Molina Healthcare is no longer in our current JPI rankings, but appeared in the past (2016) — its upside may be behind it. See the stocks picked in 2016 →

🎯 MOH price target & analyst consensusprice $199

The price target · all analysts combined (11 targets)
Highest target · 1 firm of 11$230+15.7%
Median target · of 11 targets$202+1.6%
Lowest target · 1 firm of 11$163-18.0%
Current price$198.75
Where these 11 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price 655% $202 ↔ $230
Below 545% $163 ↔ $191
⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: Truist Securities64% of its targets hit on this sector (109 calls tested). It aims for $225 (+13 %), call made on July 25, 2026, maturing on July 25, 2027 (34 d ago).

The 4 reliable analysts $223+12 %
The 7 other firms $180-9.4 %
How to read it: the 4 reliable firms are not filtered by optimism — 4 aim above the price, 0 below, hence their $223 median. “The 7 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 11 ratings (last 6 months)
Strong Buy00%
Buy19%
Hold982%
Sell19%
Strong Sell00%
Go deeper on the analysts
All analysts (the consensus)  ·  vs  ·  the best (those who've been right)
💬 A question about Molina Healthcare? The JPI assistant answers using our backtest data.

📈 Molina Healthcare fundamentals: valuation, margins & growth › open the full page

P/E 1242.2Net margin -0.0 %Revenue growth -5.7 %Very high P/E

Revenue, net income and margin per year

Revenue Net income · hover a bar for details
2022
marg. 2 %
2023
Rev +7%Profit +38%
2024
Rev +19%Profit +8%
2025
Rev +12%Profit −60%

🔎 Detailed analyses

🏛️ Which US Congress members hold Molina Healthcare (MOH)?

2 Congress members have disclosed MOH buys. Click a highlighted name to see their track record (do they beat the S&P 500?).
Daniel Goldman · 25%Earl Blumenauer · 38%
→ Full members ranking (who beats the market)

✅ Historical analyst reliability on MOH

Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.

Firm % right i Gain vs sector i Calls i
SunTrust Robinson Humphrey 100% +52.5% 3
SVB Leerink 100% +48.3% 4
Deutsche Bank  100% +47.8% 4
Piper Sandler  100% +45.5% 2
Monness, Crespi, Hardt 100% +34.5% 2
Morgan Stanley  75% +29.3% 24
BMO Capital  75% +21.3% 4
Credit Suisse 71% +9.2% 7
B of A Securities  69% +6.7% 13
Goldman Sachs  67% +3.7% 3
See the other 14 firms
Stifel  0% -28.5% 2
Baird  0% -24.9% 2
Cantor Fitzgerald  18% -27.1% 11
TD Cowen  25% -23.6% 4
Wells Fargo  38% -11.0% 13
Truist Securities  45% -9.0% 11
Susquehanna  50% -7.4% 2
Wedbush  50% +0.2% 2
Leerink Swann 50% +3.6% 4
Citigroup  50% +6.2% 2
Barclays  50% +6.6% 4
JP Morgan  55% +23.8% 11
Mizuho  56% -0.4% 9
Jefferies  64% +8.9% 11

📊 What $1,000 invested in Molina Healthcare would be worth › open the full page

In short — $1,000 invested in Molina Healthcare 10 years ago would be worth $4,017 today, i.e. +15%/yr on average. Best year: 2020 (+57%), worst: 2025 (-40%). Price performance, excluding dividends.

If I'd invested $1,000 in Molina Healthcare

InvestmentWorth todayGain
1 years ago$830-17%
3 years ago$732-27%
5 years ago$1,136+14%
→ See Molina Healthcare's full return history + gain calculator

Return by year (Molina Healthcare)

YearReturn$1,000 invested at year start
2026 (YTD)+39%$1,392 (+39%)
2025-40%$830 (-17%)
2024-19%$669 (-33%)
→ See Molina Healthcare's full return history + gain calculator
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

📰 Recent news on Molina Healthcare

Loading news…

📋 All analyst calls on MOH

Wells Fargo 
Jul 28, 26
■ Equal-Weight neutral · not a buy · 🎯$220
Price at call : $200.34 — gap to target +10%
Today : $198.75 — gap to target +11%
🎯 on MOH : 100% (1 call matured) · 📊 on Health : 47% · +4.6% (149 calls)
in progress (365j)
matures : Jul 28, 27
■ Hold neutral · not a buy · 🎯$225
Price at call : $199.48 — gap to target +13%
Today : $198.75 — gap to target +13%
🎯 on MOH : no call matured yet · 📊 on Health : 58.7% · +5.8% (109 calls)
in progress (365j)
matures : Jul 24, 27
RBC Capital 
Jul 24, 26
■ Sector Perform neutral · not a buy · 🎯$218
Price at call : $199.48 — gap to target +9%
Today : $198.75 — gap to target +10%
🎯 on MOH : no call matured yet · 📊 on Health : 49.2% · +7.0% (195 calls)
in progress (365j)
matures : Jul 24, 27
Barclays 
Jul 24, 26
▼ Underweight · 🎯$180
Price at call : $199.48 — upside -10%
Today : $198.75 — upside -9%
🎯 on MOH : no call matured yet · 📊 on Health : 47.9% · +1.6% (194 calls)
in progress (365j)
matures : Jul 24, 27
TD Cowen 
Jul 14, 26
■ Hold neutral · not a buy · 🎯$230
Price at call : $233.36 — gap to target -1%
Today : $198.75 — gap to target +16%
🎯 on MOH : no call matured yet · 📊 on Health : 53.8% · +17.8% (26 calls)
in progress (365j)
matures : Jul 14, 27
■ Hold neutral · not a buy · 🎯$250
Price at call : $233.36 — gap to target +7%
Today : $198.75 — gap to target +26%
🎯 on MOH : no call matured yet · 📊 on Health : 58.7% · +5.8% (109 calls)
in progress (365j)
matures : Jul 14, 27
Wells Fargo 
Jul 13, 26
■ Equal-Weight neutral · not a buy · 🎯$235
Price at call : $241.56 — gap to target -3%
Today : $198.75 — gap to target +18%
🎯 on MOH : 100% (1 call matured) · 📊 on Health : 47% · +4.6% (149 calls)
in progress (365j)
matures : Jul 13, 27
RBC Capital 
Jul 9, 26
■ Sector Perform neutral · not a buy · 🎯$248
Price at call : $233.31 — gap to target +6%
Today : $198.75 — gap to target +25%
🎯 on MOH : no call matured yet · 📊 on Health : 49.2% · +7.0% (195 calls)
in progress (365j)
matures : Jul 9, 27
See the other 98 calls, newest to oldest
Barclays 
Jul 9, 26
▼ Underweight · 🎯$184
Price at call : $233.31 — upside -21%
Today : $198.75 — upside -7%
🎯 on MOH : no call matured yet · 📊 on Health : 47.9% · +1.6% (194 calls)
in progress (365j)
matures : Jul 9, 27
RBC Capital 
Jun 23, 26
■ Sector Perform neutral · not a buy · 🎯$216
Price at call : $201.42 — gap to target +7%
Today : $198.75 — gap to target +9%
🎯 on MOH : no call matured yet · 📊 on Health : 49.2% · +7.0% (195 calls)
in progress (365j)
matures : Jun 23, 27
JP Morgan 
Jun 8, 26
■ Neutral neutral · not a buy · 🎯$191
Price at call : $203.06 — gap to target -6%
Today : $198.75 — gap to target -4%
🎯 on MOH : no call matured yet · 📊 on Health : 49.3% · +6.2% (142 calls)
in progress (365j)
matures : Jun 8, 27
■ Equal-Weight neutral · not a buy · 🎯$167
Price at call : $190.86 — gap to target -13%
Today : $198.75 — gap to target -16%
🎯 on MOH : 75% (12 calls matureds) · 📊 on Health : 41.3% · -1.5% (196 calls)
in progress (365j)
matures : Jun 4, 27
Barclays 
May 26, 26
▼ Underweight · 🎯$199
Price at call : $177.87 — upside +12%
Today : $198.75 — upside +0%
🎯 on MOH : no call matured yet · 📊 on Health : 47.9% · +1.6% (194 calls)
in progress (365j)
matures : May 26, 27
UBS 
May 22, 26
■ Neutral neutral · not a buy · 🎯$202
Price at call : $176.2 — gap to target +15%
Today : $198.75 — gap to target +2%
🎯 on MOH : no call matured yet · 📊 on Health : 49.6% · +18.1% (119 calls)
in progress (365j)
matures : May 22, 27
■ Hold neutral · not a buy · 🎯$205
Price at call : $191.58 — gap to target +7%
Today : $198.75 — gap to target +3%
🎯 on MOH : no call matured yet · 📊 on Health : 58.7% · +5.8% (109 calls)
in progress (365j)
matures : May 11, 27
■ Neutral neutral · not a buy · 🎯$209
Price at call : $185.19 — gap to target +13%
Today : $198.75 — gap to target +5%
🎯 on MOH : 18% (11 calls matureds) · 📊 on Health : 55.7% · +17.4% (115 calls)
in progress (365j)
matures : May 11, 27
Baird 
May 11, 26
■ Neutral neutral · not a buy · 🎯$163
Price at call : $185.19 — gap to target -12%
Today : $198.75 — gap to target -18%
🎯 on MOH : no call matured yet · 📊 on Health : 48.7% · +1.8% (76 calls)
in progress (365j)
matures : May 11, 27
Wells Fargo 
Apr 27, 26
■ Equal-Weight neutral · not a buy · 🎯$159
Price at call : $185.46 — gap to target -14%
Today : $198.75 — gap to target -20%
🎯 on MOH : 100% (1 call matured) · 📊 on Health : 47% · +4.6% (149 calls)
in progress (365j)
matures : Apr 27, 27
■ Hold neutral · not a buy · 🎯$180
Price at call : $179.22 — gap to target +0%
Today : $198.75 — gap to target -9%
🎯 on MOH : no call matured yet · 📊 on Health : 58.7% · +5.8% (109 calls)
in progress (365j)
matures : Apr 27, 27
UBS 
Apr 24, 26
■ Neutral neutral · not a buy · 🎯$180
Price at call : $179.22 — gap to target +0%
Today : $198.75 — gap to target -9%
🎯 on MOH : no call matured yet · 📊 on Health : 49.6% · +18.1% (119 calls)
in progress (365j)
matures : Apr 24, 27
Barclays 
Apr 24, 26
▼ Underweight · 🎯$161
Price at call : $179.22 — upside -10%
Today : $198.75 — upside -19%
🎯 on MOH : no call matured yet · 📊 on Health : 47.9% · +1.6% (194 calls)
in progress (365j)
matures : Apr 24, 27
Morgan Stanley 
Apr 24, 26
■ Equal-Weight neutral · not a buy · 🎯$146
Price at call : $179.22 — gap to target -19%
Today : $198.75 — gap to target -27%
🎯 on MOH : 75% (12 calls matureds) · 📊 on Health : 41.3% · -1.5% (196 calls)
in progress (365j)
matures : Apr 24, 27
UBS 
Mar 12, 26
■ Neutral neutral · not a buy · 🎯$151
Price at call : $149.2 — gap to target +1%
Today : $198.75 — gap to target -24%
🎯 on MOH : no call matured yet · 📊 on Health : 49.6% · +18.1% (119 calls)
in progress (365j)
matures : Mar 12, 27
Mizuho 
Mar 12, 26
▲ Outperform · 🎯$180
Price at call : $149.19 — upside +21%
Today : $198.75 — upside -9%
🎯 on MOH : 56% (9 calls matureds) · 📊 on Health : 57.1% · +12.3% (70 calls)
in progress (365j)
matures : Mar 12, 27
■ Equal-Weight neutral · not a buy · 🎯$128
Price at call : $147.71 — gap to target -13%
Today : $198.75 — gap to target -36%
🎯 on MOH : 75% (12 calls matureds) · 📊 on Health : 41.3% · -1.5% (196 calls)
in progress (365j)
matures : Mar 4, 27
Wells Fargo 
Feb 20, 26
■ Equal-Weight neutral · not a buy · 🎯$141
Price at call : $151 — gap to target -7%
Today : $198.75 — gap to target -29%
🎯 on MOH : 100% (1 call matured) · 📊 on Health : 47% · +4.6% (149 calls)
in progress (365j)
matures : Feb 20, 27
■ Hold neutral · not a buy · 🎯$145
Price at call : $142.61 — gap to target +2%
Today : $198.75 — gap to target -27%
🎯 on MOH : no call matured yet · 📊 on Health : 58.7% · +5.8% (109 calls)
in progress (365j)
matures : Feb 17, 27
Goldman Sachs 
Feb 12, 26
■ Neutral neutral · not a buy · 🎯$124
Price at call : $135.35 — gap to target -8%
Today : $198.75 — gap to target -38%
🎯 on MOH : no call matured yet · 📊 on Health : 57.9% · +13.8% (107 calls)
in progress (365j)
matures : Feb 12, 27
Barclays 
Feb 10, 26
▼ Underweight · 🎯$133
Price at call : $122.65 — upside +8%
Today : $198.75 — upside -33%
🎯 on MOH : no call matured yet · 📊 on Health : 47.9% · +1.6% (194 calls)
in progress (365j)
matures : Feb 10, 27
TD Cowen 
Feb 9, 26
■ Hold neutral · not a buy · 🎯$144
Price at call : $125.43 — gap to target +15%
Today : $198.75 — gap to target -28%
🎯 on MOH : no call matured yet · 📊 on Health : 53.8% · +17.8% (26 calls)
in progress (365j)
matures : Feb 9, 27
■ Neutral neutral · not a buy · 🎯$144
Price at call : $127.53 — gap to target +13%
Today : $198.75 — gap to target -28%
🎯 on MOH : 18% (11 calls matureds) · 📊 on Health : 55.7% · +17.4% (115 calls)
in progress (365j)
matures : Feb 9, 27
Wells Fargo 
Jan 7, 26
▲ Overweight · 🎯$208
Price at call : $183.5 — upside +13%
Today : $198.75 — upside +5%
🎯 on MOH : 100% (1 call matured) · 📊 on Health : 47% · +4.6% (149 calls)
in progress (365j)
matures : Jan 7, 27
Barclays 
Jan 5, 26
▼ Underweight · 🎯$164
Price at call : $182.8 — upside -10%
Today : $198.75 — upside -17%
🎯 on MOH : no call matured yet · 📊 on Health : 47.9% · +1.6% (194 calls)
in progress (365j)
matures : Jan 5, 27
Wells Fargo 
Nov 12, 25
▲ Overweight · 🎯$165
Price at call : $138.48 — upside +19%
Today : $198.75 — upside -17%
🎯 on MOH : 100% (1 call matured) · 📊 on Health : 47% · +4.6% (149 calls)
in progress (365j)
matures : Nov 12, 26
Goldman Sachs 
Oct 24, 25
■ Neutral neutral · not a buy · 🎯$167
Price at call : $162.19 — gap to target +3%
Today : $198.75 — gap to target -16%
🎯 on MOH : no call matured yet · 📊 on Health : 57.9% · +13.8% (107 calls)
in progress (365j)
matures : Oct 24, 26
UBS 
Oct 24, 25
■ Neutral neutral · not a buy · 🎯$170
Price at call : $162.19 — gap to target +5%
Today : $198.75 — gap to target -14%
🎯 on MOH : no call matured yet · 📊 on Health : 49.6% · +18.1% (119 calls)
in progress (365j)
matures : Oct 24, 26
■ Neutral neutral · not a buy · 🎯$180
Price at call : $162.19 — gap to target +11%
Today : $198.75 — gap to target -9%
🎯 on MOH : 18% (11 calls matureds) · 📊 on Health : 55.7% · +17.4% (115 calls)
in progress (365j)
matures : Oct 24, 26
Barclays 
Oct 24, 25
▼ Underweight · 🎯$144
Price at call : $163.32 — upside -12%
Today : $198.75 — upside -28%
🎯 on MOH : no call matured yet · 📊 on Health : 47.9% · +1.6% (194 calls)
in progress (365j)
matures : Oct 24, 26
Morgan Stanley 
Oct 14, 25
■ Equal-Weight neutral · not a buy · 🎯$204
Price at call : $192.39 — gap to target +6%
Today : $198.75 — gap to target +3%
🎯 on MOH : 75% (12 calls matureds) · 📊 on Health : 41.3% · -1.5% (196 calls)
in progress (365j)
matures : Oct 14, 26
Goldman Sachs 
Oct 14, 25
■ Neutral neutral · not a buy · 🎯$207
Price at call : $194.89 — gap to target +6%
Today : $198.75 — gap to target +4%
🎯 on MOH : no call matured yet · 📊 on Health : 57.9% · +13.8% (107 calls)
in progress (365j)
matures : Oct 14, 26
Wells Fargo 
Oct 7, 25
▲ Overweight · 🎯$231
Price at call : $202.92 — upside +14%
Today : $198.75 — upside +16%
🎯 on MOH : 100% (1 call matured) · 📊 on Health : 47% · +4.6% (149 calls)
in progress (365j)
matures : Oct 7, 26
Bernstein 
Sep 5, 25
▲ Outperform · 🎯$220
Price at call : $175.55 — upside +25%
Today : $198.75 — upside +11%
🎯 on MOH : 0% (1 call matured) · 📊 on Health : 50% · -5.0% (6 calls)
in progress (365j)
matures : Sep 5, 26
Barclays 
Sep 4, 25
■ Equal-Weight neutral · not a buy · 🎯$185
Price at call : $174.65 — gap to target +6%
Today : $198.75 — gap to target -7%
🎯 on MOH : no call matured yet · 📊 on Health : 47.9% · +1.6% (194 calls)
in progress (365j)
matures : Sep 4, 26
■ Neutral neutral · not a buy · 🎯$210
Price at call : $174.78 — gap to target +20%
Today : $198.75 — gap to target +6%
🎯 on MOH : 18% (11 calls matureds) · 📊 on Health : 55.7% · +17.4% (115 calls)
in progress (365j)
matures : Aug 26, 26
Wells Fargo 
Aug 15, 25
▲ Overweight · 🎯$198
Price at call : $167.49 — upside +18%
Today : $198.75 — upside -0%
Expected +18% · Actual +21% · Reason (≥ +15%) : ✓ Yes
🎯 on MOH : 100% (1 call matured) · 📊 on Health : 47% · +4.6% (149 calls)
+21.2%
stock +21% · XLV +23%
matured Aug 15, 26
JP Morgan 
Jul 29, 25
■ Neutral neutral · not a buy · 🎯$184
Price at call : $159.97 — gap to target +15%
Today : $198.75 — gap to target -7%
🎯 on MOH : no call matured yet · 📊 on Health : 49.3% · +6.2% (142 calls)
in progress (365j)
matures : Jul 29, 26
UBS 
Jul 25, 25
■ Neutral neutral · not a buy · 🎯$180
Price at call : $164.19 — gap to target +10%
Today : $198.75 — gap to target -9%
🎯 on MOH : no call matured yet · 📊 on Health : 49.6% · +18.1% (119 calls)
in progress (365j)
matures : Jul 25, 26
■ Hold neutral · not a buy · 🎯$180
Price at call : $164.19 — gap to target +10%
Today : $198.75 — gap to target -9%
🎯 on MOH : no call matured yet · 📊 on Health : 58.7% · +5.8% (109 calls)
in progress (365j)
matures : Jul 25, 26
Barclays 
Jul 25, 25
■ Equal-Weight neutral · not a buy · 🎯$186
Price at call : $164.19 — gap to target +13%
Today : $198.75 — gap to target -6%
🎯 on MOH : no call matured yet · 📊 on Health : 47.9% · +1.6% (194 calls)
in progress (365j)
matures : Jul 25, 26
■ Neutral neutral · not a buy · 🎯$210
Price at call : $165.02 — gap to target +27%
Today : $198.75 — gap to target +6%
🎯 on MOH : 18% (11 calls matureds) · 📊 on Health : 55.7% · +17.4% (115 calls)
in progress (365j)
matures : Jul 25, 26
Mizuho 
Jul 11, 25
▲ Outperform · 🎯$330
Price at call : $218.95 — upside +51%
Today : $198.75 — upside +66%
Expected +51% · Actual +11% · Reason (≥ +15%) : ✗ No
🎯 on MOH : 56% (9 calls matureds) · 📊 on Health : 57.1% · +12.3% (70 calls)
+10.9%
stock +11% · XLV +20%
matured Jul 11, 26
▲ Overweight · 🎯$364
Price at call : $295.69 — upside +23%
Today : $198.75 — upside +83%
Expected +23% · Actual -33% · Reason (≥ +15%) : ✗ No
🎯 on MOH : 75% (12 calls matureds) · 📊 on Health : 41.3% · -1.5% (196 calls)
-33.1%
stock -33% · XLV +13%
matured Jun 9, 26
Bernstein 
Apr 22, 25
▲ Outperform · 🎯$414
Price at call : $332 — upside +25%
Today : $198.75 — upside +108%
Expected +25% · Actual -47% · Reason (≥ +15%) : ✗ No
🎯 on MOH : 0% (1 call matured) · 📊 on Health : 50% · -5.0% (6 calls)
-47.4%
stock -47% · XLV +8%
matured Apr 22, 26
Mizuho 
Apr 9, 25
▲ Outperform · 🎯$400
Price at call : $340.09 — upside +18%
Today : $198.75 — upside +101%
Expected +18% · Actual -57% · Reason (≥ +15%) : ✗ No
🎯 on MOH : 56% (9 calls matureds) · 📊 on Health : 57.1% · +12.3% (70 calls)
-57.4%
stock -57% · XLV +8%
matured Apr 9, 26
Mizuho 
Mar 3, 25
▲ Outperform · 🎯$376
Price at call : $306.49 — upside +23%
Today : $198.75 — upside +89%
Expected +23% · Actual -51% · Reason (≥ +15%) : ✗ No
🎯 on MOH : 56% (9 calls matureds) · 📊 on Health : 57.1% · +12.3% (70 calls)
-51.0%
stock -51% · XLV +6%
matured Mar 3, 26
▲ Overweight · 🎯$406
Price at call : $325.54 — upside +25%
Today : $198.75 — upside +104%
Expected +25% · Actual -50% · Reason (≥ +15%) : ✗ No
🎯 on MOH : 18% (11 calls matureds) · 📊 on Health : 55.7% · +17.4% (115 calls)
-50.2%
stock -50% · XLV -1%
matured Oct 24, 25
▲ Overweight · 🎯$406
Price at call : $331.8 — upside +22%
Today : $198.75 — upside +104%
Expected +22% · Actual -41% · Reason (≥ +15%) : ✗ No
🎯 on MOH : 18% (11 calls matureds) · 📊 on Health : 55.7% · +17.4% (115 calls)
-41.5%
stock -41% · XLV -6%
matured Oct 1, 25
▲ Overweight · 🎯$406
Price at call : $344.73 — upside +18%
Today : $198.75 — upside +104%
Expected +18% · Actual -45% · Reason (≥ +15%) : ✗ No
🎯 on MOH : 18% (11 calls matureds) · 📊 on Health : 55.7% · +17.4% (115 calls)
-45.3%
stock -45% · XLV -10%
matured Sep 10, 25
▲ Overweight · 🎯$406
Price at call : $348.5 — upside +16%
Today : $198.75 — upside +104%
Expected +16% · Actual -50% · Reason (≥ +15%) : ✗ No
🎯 on MOH : 18% (11 calls matureds) · 📊 on Health : 55.7% · +17.4% (115 calls)
-50.2%
stock -50% · XLV -11%
matured Aug 19, 25
▲ Overweight · 🎯$406
Price at call : $335.36 — upside +21%
Today : $198.75 — upside +104%
Expected +21% · Actual -51% · Reason (≥ +15%) : ✗ No
🎯 on MOH : 18% (11 calls matureds) · 📊 on Health : 55.7% · +17.4% (115 calls)
-51.0%
stock -51% · XLV -10%
matured Jul 25, 25
▲ Overweight · 🎯$406
Price at call : $288.72 — upside +41%
Today : $198.75 — upside +104%
Expected +41% · Actual -45% · Reason (≥ +15%) : ✗ No
🎯 on MOH : 18% (11 calls matureds) · 📊 on Health : 55.7% · +17.4% (115 calls)
-45.2%
stock -45% · XLV -9%
matured Jul 23, 25
▲ Overweight · 🎯$406
Price at call : $376.77 — upside +8%
Today : $198.75 — upside +104%
Expected +8% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on MOH : 18% (11 calls matureds) · 📊 on Health : 55.7% · +17.4% (115 calls)
-9.7%
stock -10% · XLV -6%
matured Apr 4, 25
▼ Underperform · 🎯$439
Price at call : $404.2 — upside +9%
Today : $198.75 — upside +121%
Expected +9% · Actual -19% · Reason (≤ −15%) : ✓ Yes
🎯 on MOH : 67% (12 calls matureds) · 📊 on Health : 64.8% · +20.2% (105 calls)
+18.9%
stock -19% · XLV -2%
matured Apr 1, 25
▼ Underperform · 🎯$439
Price at call : $410.83 — upside +7%
Today : $198.75 — upside +121%
Expected +7% · Actual -21% · Reason (≤ −15%) : ✓ Yes
🎯 on MOH : 67% (12 calls matureds) · 📊 on Health : 64.8% · +20.2% (105 calls)
+21.4%
stock -21% · XLV -2%
matured Mar 28, 25
▲ Overweight · 🎯$406
Price at call : $392.63 — upside +3%
Today : $198.75 — upside +104%
Expected +3% · Actual -27% · Reason (≥ +15%) : ✗ No
🎯 on MOH : 18% (11 calls matureds) · 📊 on Health : 55.7% · +17.4% (115 calls)
-27.1%
stock -27% · XLV +1%
matured Feb 8, 25
▲ Overweight · 🎯$374
Price at call : $364.87 — upside +3%
Today : $198.75 — upside +88%
Expected +3% · Actual -19% · Reason (≥ +15%) : ✗ No
🎯 on MOH : 18% (11 calls matureds) · 📊 on Health : 55.7% · +17.4% (115 calls)
-18.9%
stock -19% · XLV +10%
matured Nov 20, 24
▲ Overweight · 🎯$359
Price at call : $327.6 — upside +10%
Today : $198.75 — upside +81%
Expected +10% · Actual +10% · Reason (≥ +15%) : ✗ No
🎯 on MOH : 18% (11 calls matureds) · 📊 on Health : 55.7% · +17.4% (115 calls)
+10.1%
stock +10% · XLV +19%
matured Sep 13, 24
Morgan Stanley 
Jul 14, 23
▲ Overweight · 🎯$365
Price at call : $299.91 — upside +22%
Today : $198.75 — upside +84%
Expected +22% · Actual -5% · Reason (≥ +15%) : ✗ No
🎯 on MOH : 75% (12 calls matureds) · 📊 on Health : 41.3% · -1.5% (196 calls)
-5.3%
stock -5% · XLV +13%
matured Jul 13, 24
▲ Overweight · 🎯$354
Price at call : $275.54 — upside +28%
Today : $198.75 — upside +78%
Expected +28% · Actual +31% · Reason (≥ +15%) : ✓ Yes
🎯 on MOH : 18% (11 calls matureds) · 📊 on Health : 55.7% · +17.4% (115 calls)
+31.3%
stock +31% · XLV +4%
matured Apr 20, 24
Mizuho 
Jul 29, 22
▲ Buy · 🎯$366
Price at call : $327.72 — upside +12%
Today : $198.75 — upside +84%
Expected +12% · Actual -7% · Reason (≥ +15%) : ✗ No
🎯 on MOH : 56% (9 calls matureds) · 📊 on Health : 57.1% · +12.3% (70 calls)
-7.1%
stock -7% · XLV +1%
matured Jul 29, 23
▼ Underperform · 🎯$335
Price at call : $299.02 — upside +12%
Today : $198.75 — upside +69%
Expected +12% · Actual -9% · Reason (≤ −15%) : ✗ No
🎯 on MOH : 67% (12 calls matureds) · 📊 on Health : 64.8% · +20.2% (105 calls)
+8.7%
stock -9% · XLV -3%
matured May 26, 23
Morgan Stanley 
Feb 22, 22
▲ Overweight · 🎯$365
Price at call : $307.68 — upside +19%
Today : $198.75 — upside +84%
Expected +19% · Actual -4% · Reason (≥ +15%) : ✗ No
🎯 on MOH : 75% (12 calls matureds) · 📊 on Health : 41.3% · -1.5% (196 calls)
-4.4%
stock -4% · XLV +2%
matured Feb 22, 23
Mizuho 
Feb 11, 22
▲ Buy · 🎯$345
Price at call : $303.23 — upside +14%
Today : $198.75 — upside +74%
Expected +14% · Actual -1% · Reason (≥ +15%) : ✗ No
🎯 on MOH : 56% (9 calls matureds) · 📊 on Health : 57.1% · +12.3% (70 calls)
-1.3%
stock -1% · XLV +3%
matured Feb 11, 23
Morgan Stanley 
Oct 29, 21
▲ Overweight · 🎯$397
Price at call : $297.97 — upside +33%
Today : $198.75 — upside +100%
Expected +33% · Actual +20% · Reason (≥ +15%) : ✓ Yes
🎯 on MOH : 75% (12 calls matureds) · 📊 on Health : 41.3% · -1.5% (196 calls)
+20.4%
stock +20% · XLV -1%
matured Oct 29, 22
Morgan Stanley 
Sep 20, 21
▲ Overweight · 🎯$316
Price at call : $277.39 — upside +14%
Today : $198.75 — upside +59%
Expected +14% · Actual +22% · Reason (≥ +15%) : ✓ Yes
🎯 on MOH : 75% (12 calls matureds) · 📊 on Health : 41.3% · -1.5% (196 calls)
+21.8%
stock +22% · XLV -5%
matured Sep 20, 22
Mizuho 
Sep 20, 21
▲ Buy · 🎯$305
Price at call : $277.39 — upside +10%
Today : $198.75 — upside +53%
Expected +10% · Actual +22% · Reason (≥ +15%) : ✓ Yes
🎯 on MOH : 56% (9 calls matureds) · 📊 on Health : 57.1% · +12.3% (70 calls)
+21.8%
stock +22% · XLV -5%
matured Sep 20, 22
Morgan Stanley 
Aug 31, 21
▲ Overweight · 🎯$296
Price at call : $268.77 — upside +10%
Today : $198.75 — upside +49%
Expected +10% · Actual +26% · Reason (≥ +15%) : ✓ Yes
🎯 on MOH : 75% (12 calls matureds) · 📊 on Health : 41.3% · -1.5% (196 calls)
+25.5%
stock +26% · XLV -8%
matured Aug 31, 22
Mizuho 
Jul 30, 21
▲ Buy · 🎯$284
Price at call : $273.01 — upside +4%
Today : $198.75 — upside +43%
Expected +4% · Actual +19% · Reason (≥ +15%) : ✓ Yes
🎯 on MOH : 56% (9 calls matureds) · 📊 on Health : 57.1% · +12.3% (70 calls)
+19.0%
stock +19% · XLV -1%
matured Jul 30, 22
▲ Overweight · 🎯$297
Price at call : $249 — upside +19%
Today : $198.75 — upside +49%
Expected +19% · Actual +15% · Reason (≥ +15%) : ✓ Yes
🎯 on MOH : 75% (12 calls matureds) · 📊 on Health : 41.3% · -1.5% (196 calls)
+15.1%
stock +15% · XLV +6%
matured Jun 3, 22
Mizuho 
Apr 30, 21
▲ Buy · 🎯$273
Price at call : $256.23 — upside +7%
Today : $198.75 — upside +37%
Expected +7% · Actual +20% · Reason (≥ +15%) : ✓ Yes
🎯 on MOH : 56% (9 calls matureds) · 📊 on Health : 57.1% · +12.3% (70 calls)
+19.6%
stock +20% · XLV +6%
matured Apr 30, 22
Mizuho 
Mar 10, 21
▲ Buy · 🎯$245
Price at call : $223.47 — upside +10%
Today : $198.75 — upside +23%
Expected +10% · Actual +42% · Reason (≥ +15%) : ✓ Yes
🎯 on MOH : 56% (9 calls matureds) · 📊 on Health : 57.1% · +12.3% (70 calls)
+41.5%
stock +42% · XLV +14%
matured Mar 10, 22
Morgan Stanley 
May 15, 20
▲ Overweight · 🎯$229
Price at call : $181.42 — upside +26%
Today : $198.75 — upside +15%
Expected +26% · Actual +44% · Reason (≥ +15%) : ✓ Yes
🎯 on MOH : 75% (12 calls matureds) · 📊 on Health : 41.3% · -1.5% (196 calls)
+44.4%
stock +44% · XLV +23%
matured May 15, 21
Morgan Stanley 
Apr 13, 20
▲ Overweight · 🎯$175
Price at call : $163.29 — upside +7%
Today : $198.75 — upside -12%
Expected +7% · Actual +50% · Reason (≥ +15%) : ✓ Yes
🎯 on MOH : 75% (12 calls matureds) · 📊 on Health : 41.3% · -1.5% (196 calls)
+49.5%
stock +50% · XLV +22%
matured Apr 13, 21
▲ Buy
Actual +57% · Reason (≥ +15%) : ✓ Yes
🎯 on MOH : 67% (12 calls matureds) · 📊 on Health : 64.8% · +20.2% (105 calls)
+57.2%
stock +57% · XLV +24%
matured Apr 8, 21
Morgan Stanley 
Mar 27, 20
▲ Overweight · 🎯$165
Price at call : $139.35 — upside +18%
Today : $198.75 — upside -17%
Expected +18% · Actual +67% · Reason (≥ +15%) : ✓ Yes
🎯 on MOH : 75% (12 calls matureds) · 📊 on Health : 41.3% · -1.5% (196 calls)
+67.4%
stock +67% · XLV +32%
matured Mar 27, 21
Morgan Stanley 
Oct 31, 19
▲ Overweight · 🎯$158
Price at call : $117.64 — upside +34%
Today : $198.75 — upside -21%
Expected +34% · Actual +59% · Reason (≥ +15%) : ✓ Yes
🎯 on MOH : 75% (12 calls matureds) · 📊 on Health : 41.3% · -1.5% (196 calls)
+58.5%
stock +59% · XLV +7%
matured Oct 30, 20
Morgan Stanley 
Aug 23, 19
▲ Overweight · 🎯$172
Price at call : $127.33 — upside +35%
Today : $198.75 — upside -13%
Expected +35% · Actual +43% · Reason (≥ +15%) : ✓ Yes
🎯 on MOH : 75% (12 calls matureds) · 📊 on Health : 41.3% · -1.5% (196 calls)
+42.6%
stock +43% · XLV +20%
matured Aug 22, 20
Jefferies 
Nov 13, 18
▲ Buy · 🎯$169
Price at call : $135.36 — upside +25%
Today : $198.75 — upside -15%
Expected +25% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on MOH : 64% (11 calls matureds) · 📊 on Health : 49.1% · +10.3% (112 calls)
-10.2%
stock -10% · XLV +5%
matured Nov 13, 19
▼ Underperform · 🎯$110
Price at call : $128.35 — upside -14%
Today : $198.75 — upside -45%
Expected -14% · Actual +1% · Reason (≤ −15%) : ✗ No
🎯 on MOH : 67% (12 calls matureds) · 📊 on Health : 64.8% · +20.2% (105 calls)
-0.7%
stock +1% · XLV +2%
matured Aug 1, 19
▼ Underperform · 🎯$94
Price at call : $106.38 — upside -12%
Today : $198.75 — upside -53%
Expected -12% · Actual +27% · Reason (≤ −15%) : ✗ No
🎯 on MOH : 67% (12 calls matureds) · 📊 on Health : 64.8% · +20.2% (105 calls)
-27.4%
stock +27% · XLV +3%
matured Jul 24, 19
Jefferies 
Jun 22, 18
▲ Buy
Actual +45% · Reason (≥ +15%) : ✓ Yes
🎯 on MOH : 64% (11 calls matureds) · 📊 on Health : 49.1% · +10.3% (112 calls)
+45.2%
stock +45% · XLV +10%
matured Jun 22, 19
▼ Underperform · 🎯$60
Price at call : $70.26 — upside -15%
Today : $198.75 — upside -70%
Expected -15% · Actual +51% · Reason (≤ −15%) : ✗ No
🎯 on MOH : 67% (12 calls matureds) · 📊 on Health : 64.8% · +20.2% (105 calls)
-50.8%
stock +51% · XLV +9%
matured Jul 14, 18
Jefferies 
Sep 13, 16
▲ Buy · 🎯$70
Price at call : $54.81 — upside +28%
Today : $198.75 — upside -65%
Expected +28% · Actual +21% · Reason (≥ +15%) : ✓ Yes
🎯 on MOH : 64% (11 calls matureds) · 📊 on Health : 49.1% · +10.3% (112 calls)
+20.5%
stock +21% · XLV +16%
matured Sep 13, 17
Jefferies 
Jul 28, 16
▲ Buy · 🎯$63
Price at call : $56.81 — upside +11%
Today : $198.75 — upside -68%
Expected +11% · Actual +18% · Reason (≥ +15%) : ✓ Yes
🎯 on MOH : 64% (11 calls matureds) · 📊 on Health : 49.1% · +10.3% (112 calls)
+17.6%
stock +18% · XLV +6%
matured Jul 28, 17
▼ Underperform
Actual -2% · Reason (≤ −15%) : ✗ No
🎯 on MOH : 67% (12 calls matureds) · 📊 on Health : 64.8% · +20.2% (105 calls)
+1.8%
stock -2% · XLV +8%
matured Apr 29, 17
Jefferies 
Jan 8, 16
▲ Buy · 🎯$73
Price at call : $55.93 — upside +31%
Today : $198.75 — upside -63%
Expected +31% · Actual +2% · Reason (≥ +15%) : ✗ No
🎯 on MOH : 64% (11 calls matureds) · 📊 on Health : 49.1% · +10.3% (112 calls)
+1.5%
stock +2% · XLV +6%
matured Jan 7, 17
Jefferies 
Jul 15, 15
▲ Buy · 🎯$84
Price at call : $72.71 — upside +16%
Today : $198.75 — upside -58%
Expected +16% · Actual -28% · Reason (≥ +15%) : ✗ No
🎯 on MOH : 64% (11 calls matureds) · 📊 on Health : 49.1% · +10.3% (112 calls)
-28.5%
stock -28% · XLV -4%
matured Jul 14, 16
Jefferies 
May 8, 15
▲ Buy · 🎯$80
Price at call : $65.12 — upside +23%
Today : $198.75 — upside -60%
Expected +23% · Actual -28% · Reason (≥ +15%) : ✗ No
🎯 on MOH : 64% (11 calls matureds) · 📊 on Health : 49.1% · +10.3% (112 calls)
-27.6%
stock -28% · XLV -5%
matured May 7, 16
▲ Buy · 🎯$57
Price at call : $50.77 — upside +12%
Today : $198.75 — upside -71%
Expected +12% · Actual +25% · Reason (≥ +15%) : ✓ Yes
🎯 on MOH : 67% (12 calls matureds) · 📊 on Health : 64.8% · +20.2% (105 calls)
+24.9%
stock +25% · XLV +5%
matured Nov 18, 15
Jefferies 
Aug 2, 14
▲ Buy · 🎯$50
Price at call : $41.7 — upside +20%
Today : $198.75 — upside -75%
Expected +20% · Actual +84% · Reason (≥ +15%) : ✓ Yes
🎯 on MOH : 64% (11 calls matureds) · 📊 on Health : 49.1% · +10.3% (112 calls)
+83.7%
stock +84% · XLV +25%
matured Aug 2, 15
Jefferies 
Jul 11, 14
▲ Buy · 🎯$54
Price at call : $45.54 — upside +19%
Today : $198.75 — upside -73%
Expected +19% · Actual +53% · Reason (≥ +15%) : ✓ Yes
🎯 on MOH : 64% (11 calls matureds) · 📊 on Health : 49.1% · +10.3% (112 calls)
+53.2%
stock +53% · XLV +23%
matured Jul 11, 15
▲ Buy · 🎯$44
Price at call : $39.08 — upside +13%
Today : $198.75 — upside -78%
Expected +13% · Actual +53% · Reason (≥ +15%) : ✓ Yes
🎯 on MOH : 67% (12 calls matureds) · 📊 on Health : 64.8% · +20.2% (105 calls)
+53.0%
stock +53% · XLV +27%
matured May 2, 15
Jefferies 
Sep 16, 13
▲ Buy · 🎯$47
Price at call : $39.13 — upside +20%
Today : $198.75 — upside -76%
Expected +20% · Actual +14% · Reason (≥ +15%) : ✗ No
🎯 on MOH : 64% (11 calls matureds) · 📊 on Health : 49.1% · +10.3% (112 calls)
+14.0%
stock +14% · XLV +25%
matured Sep 16, 14
▲ Buy · 🎯$41
Price at call : $32.99 — upside +24%
Today : $198.75 — upside -79%
Expected +24% · Actual +7% · Reason (≥ +15%) : ✗ No
🎯 on MOH : 67% (12 calls matureds) · 📊 on Health : 64.8% · +20.2% (105 calls)
+7.2%
stock +7% · XLV +34%
matured Feb 13, 14
▼ Underperform · 🎯$23
Price at call : $25.82 — upside -11%
Today : $198.75 — upside -88%
Expected -11% · Actual +34% · Reason (≤ −15%) : ✗ No
🎯 on MOH : 67% (12 calls matureds) · 📊 on Health : 64.8% · +20.2% (105 calls)
-34.4%
stock +34% · XLV +30%
matured Oct 24, 13
Jefferies 
Sep 18, 12
▼ Underperform · 🎯$19
Price at call : $22.49 — upside -16%
Today : $198.75 — upside -90%
Expected -16% · Actual +71% · Reason (≤ −15%) : ✗ No
🎯 on MOH : 64% (11 calls matureds) · 📊 on Health : 49.1% · +10.3% (112 calls)
-71.3%
stock +71% · XLV +30%
matured Sep 18, 13

Frequently asked questions

Should I buy Molina Healthcare stock?

This isn't buy advice. For Molina Healthcare, the analyst consensus is "Hold", with an average price target of $202 (+2% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (3 calls tracked on Molina Healthcare). We show the numbers — you decide.

Is it too late to buy Molina Healthcare? How high can it go?

The most bullish analyst target on Molina Healthcare is $230 (+16% above today's price); the average is $202. That's the upside they see. Check how reliable those analysts have actually been on Molina Healthcare on our site before trusting it.

Is Molina Healthcare still a good buy?

The most useful "opinion" isn't an opinion — it's a track record: 24 analysts have a real record on Molina Healthcare, the best hitting 100% over 3 calls. Current consensus: "Hold". Make your call on data, not noise.

Should you invest in Molina Healthcare? The case for and against

The arguments for and against, one by one, from the numbers: why invest in MOH (and why hesitate).

What has Molina Healthcare's past performance been?

Historical returns and a "how much if I had invested" calculator: MOH performance & returns.

What is the best month to buy MOH?

The 12 months ranked by the stock's past returns: best & worst month to buy MOH.

Are insiders buying MOH stock?

Executives' and large holders' buys and sells, decoded: insider buying on MOH.

Other Health stocks

Go further

JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)